Stéphane Bardet

595 total citations
17 papers, 358 citations indexed

About

Stéphane Bardet is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Stéphane Bardet has authored 17 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Surgery and 4 papers in Genetics. Recurrent topics in Stéphane Bardet's work include Thyroid Cancer Diagnosis and Treatment (7 papers), Adrenal and Paraganglionic Tumors (4 papers) and Pancreatic function and diabetes (4 papers). Stéphane Bardet is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (7 papers), Adrenal and Paraganglionic Tumors (4 papers) and Pancreatic function and diabetes (4 papers). Stéphane Bardet collaborates with scholars based in France, Luxembourg and Türkiye. Stéphane Bardet's co-authors include B Charbonnel, V. Rohmer, Camille Buffet, Renaud Ciappuccini, Yves Reznik, Sophie Leboulleux, Pierre Véra, Slimane Zerdoud, Olivier Morel and Marie‐Elisabeth Toubert and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetologia and The Lancet Diabetes & Endocrinology.

In The Last Decade

Stéphane Bardet

16 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphane Bardet France 9 312 227 64 42 33 17 358
Danielle M. Richman United States 10 208 0.7× 158 0.7× 78 1.2× 45 1.1× 20 0.6× 14 325
Mongkol Boonsripitayanon Thailand 9 276 0.9× 171 0.8× 52 0.8× 62 1.5× 21 0.6× 10 350
Giulia Sapuppo Italy 11 241 0.8× 190 0.8× 33 0.5× 53 1.3× 32 1.0× 19 328
Ha Kyoung Park South Korea 10 273 0.9× 238 1.0× 54 0.8× 21 0.5× 6 0.2× 34 324
I. Igerc Austria 6 170 0.5× 129 0.6× 155 2.4× 16 0.4× 22 0.7× 10 326
Nobuhiro Fukunari Japan 9 262 0.8× 176 0.8× 29 0.5× 47 1.1× 4 0.1× 17 296
S. Matschnig Austria 8 185 0.6× 86 0.4× 140 2.2× 19 0.5× 22 0.7× 8 294
Waltraud Eichhorn Germany 7 161 0.5× 135 0.6× 20 0.3× 24 0.6× 12 0.4× 8 312
Roberto Maria Romano Italy 8 120 0.4× 95 0.4× 20 0.3× 20 0.5× 28 0.8× 9 246

Countries citing papers authored by Stéphane Bardet

Since Specialization
Citations

This map shows the geographic impact of Stéphane Bardet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Bardet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Bardet more than expected).

Fields of papers citing papers by Stéphane Bardet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Bardet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Bardet. The network helps show where Stéphane Bardet may publish in the future.

Co-authorship network of co-authors of Stéphane Bardet

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Bardet. A scholar is included among the top collaborators of Stéphane Bardet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Bardet. Stéphane Bardet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Cao, Christine Do, Yann Godbert, Stéphane Bardet, et al.. (2025). ENDOCAN TUTHYREF network consensus recommendations: Refractory follicular-derived thyroid cancer. Annales d Endocrinologie. 86(4). 101735–101735.
2.
Lasolle, Hélène, Jonathan Lopez, François Pattou, et al.. (2022). SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Role of molecular tests for cytologically indeterminate thyroid nodules. Annales d Endocrinologie. 83(6). 395–400. 7 indexed citations
3.
Bardet, Stéphane, Nicolas Goardon, Justine Lequesne, et al.. (2020). Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study. Endocrine. 71(2). 407–417. 16 indexed citations
5.
Ciappuccini, Renaud, et al.. (2019). Thyroid Incidentaloma on 18F-fluorocholine PET/CT and 68Ga-PSMA PET/CT Revealing a Medullary Thyroid Carcinoma. Clinical Nuclear Medicine. 44(8). 663–665. 20 indexed citations
6.
Schlumberger, Martin, Sophie Leboulleux, Bogdan Catargi, et al.. (2018). Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial. The Lancet Diabetes & Endocrinology. 6(8). 618–626. 103 indexed citations
7.
Bardet, Stéphane, Renaud Ciappuccini, Claire Pellot‐Barakat, et al.. (2017). Shear Wave Elastography in Thyroid Nodules with Indeterminate Cytology: Results of a Prospective Bicentric Study. Thyroid. 27(11). 1441–1449. 39 indexed citations
8.
Bardet, Stéphane, B Chamontin, Claire Douillard, et al.. (2016). SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis. Annales d Endocrinologie. 77(3). 208–213. 21 indexed citations
9.
Krieger, Sophie, G. Planchard, Agnès Hardouin, et al.. (2012). Assessment ofSPAG9Transcript in Fine Needle Aspirates of Thyroid Nodules. European Thyroid Journal. 1(2). 118–121. 2 indexed citations
10.
Tabarin, Antoine, Stéphane Bardet, Jérôme Bertherat, et al.. (2008). Exploration et prise en charge des incidentalomes surrénaliens. Consensus d’experts de la Société française d’endocrinologie. Annales d Endocrinologie. 69(6). e1–e16. 3 indexed citations
11.
Reznik, Yves, Hervé Lefèbvre, V. Rohmer, et al.. (2004). Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study. Clinical Endocrinology. 61(3). 311–319. 50 indexed citations
12.
Bardet, Stéphane, V. Rohmer, Arnaud Murat, et al.. (1996). 131I‐6β‐Iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clinical Endocrinology. 44(5). 587–596. 55 indexed citations
13.
Bardet, Stéphane, et al.. (1994). [Discovery of an insulinoma during the first trimester of pregnancy].. PubMed. 23(6). 285–7. 4 indexed citations
14.
Bardet, Stéphane, D Maugendre, Lucy Chaillous, et al.. (1994). Predictive value of age-related acute insulin response to glucose in subjects at risk for type 1 diabetes: results of a 6-year follow-up study from west-France.. PubMed. 19(4). 372–80. 3 indexed citations
15.
Sémana, G., Stéphane Bardet, D Maugendre, et al.. (1991). Genetic susceptibility linked to DR4 haplotypes in diabetes of type‐la or associated with polyendocrinopathies (type‐lb). Tissue Antigens. 38(4). 183–185. 1 indexed citations
16.
Bardet, Stéphane, V. Rohmer, D Maugendre, et al.. (1991). Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for Type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 34(9). 648–654. 17 indexed citations
17.
Bardet, Stéphane, V. Rohmer, D Maugendre, et al.. (1990). β-Cell Cytoadherent Lymphocytes in Some Subjects at Risk for Type 1 (Insulin-Dependent) Diabetes: Progression to Diabetes within 2 Years*. The Journal of Clinical Endocrinology & Metabolism. 71(5). 1310–1317. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026